Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Eurofins Scientific    ERF   FR0014000MR3

EUROFINS SCIENTIFIC

(ERF)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Eurofins Scientific : Diagnostics group Eurofins to expand COVID-19 testing, sets new 2022 goals

10/22/2020 | 01:28am EST

PARIS, Oct 22 (Reuters) - Laboratory testing and diagnostics company Eurofins set new financial targets for 2022 as it expands its offering for coronavirus testing, while posting third-quarter results on Thursday.

The company said it would expand such testing to include influenza and respiratory viruses, hoping to achieve revenues of 5.7 billion euros ($6.8 billion) by 2022.

"The group is introducing 2022 objectives, as 2022 should hopefully be the first year where the pandemic is brought under control," Eurofins said in a statement. ($1=0.8442 euros) (Reporting by Sudip Kar-Gupta; Editing by Clarence Fernandez)


© Reuters 2020
All news about EUROFINS SCIENTIFIC
01/15Eurofins Launches New Test, Increased Capacity to Detect SARS-CoV-2 Variants
MT
01/15EUROFINS : the global leader in analytical testing, expands worldwide face mask ..
BU
01/15EUROFINS SCIENTIFIC : Launches New Tests and Massive Capacity for Detecting and ..
BU
01/11EUROFINS SCIENTIFIC : Anti-COVID-19 System Gets Emergency Response Validation PT..
MT
01/11EUROFINS SCIENTIFIC : GeneScan Technologies Announces AOAC PTM Accreditation for..
BU
2020EUROFINS SCIENTIFIC : Launches Full-Length COVID-19Viral Genome Sequencing Servi..
MT
2020EUROFINS SCIENTIFIC : Genomics Launches Cost-Effective SARS-CoV-2 full-length Vi..
BU
2020EUROFINS CEREP : Launches PCR COVID-19 Self-Test In Germany, Spain
MT
2020EUROFINS SCIENTIFIC : launches COVID-19 PCR tests with at-home self-sampling opt..
PU
2020EUROFINS SCIENTIFIC : Lifts FY20 Revenue, Profit Outlook On Strong Trading, Orga..
MT
More news
Financials
Sales 2020 5 265 M 6 357 M 6 357 M
Net income 2020 391 M 473 M 473 M
Net Debt 2020 2 866 M 3 460 M 3 460 M
P/E ratio 2020 34,7x
Yield 2020 0,67%
Capitalization 14 262 M 17 243 M 17 221 M
EV / Sales 2020 3,25x
EV / Sales 2021 3,01x
Nbr of Employees 48 000
Free-Float 66,7%
Chart EUROFINS SCIENTIFIC
Duration : Period :
Eurofins Scientific Technical Analysis Chart | ERF | FR0014000MR3 | MarketScreener
Technical analysis trends EUROFINS SCIENTIFIC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 73,55 €
Last Close Price 74,75 €
Spread / Highest target 13,8%
Spread / Average Target -1,60%
Spread / Lowest Target -48,9%
EPS Revisions
Managers and Directors
NameTitle
Gilles J. Martin Chairman & Chief Executive Officer
Laurent Lebras Director-Group Finance & Administration
Andreas König Chief Information Officer
Yves-Loïc Martin Non-Executive Director
Valérie Hanote Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
EUROFINS SCIENTIFIC8.92%17 243
SQUARE, INC.4.65%102 701
FISERV, INC.-4.97%72 541
GLOBAL PAYMENTS INC.-11.16%57 287
CINTAS CORPORATION-7.75%34 247
OFFCN EDUCATION TECHNOLOGY CO., LTD.-5.21%31 695